Literature DB >> 29087506

Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata.

Sara Barbosa Salazar1, Can Wang2, Martin Münsterkötter3, Michiyo Okamoto4, Azusa Takahashi-Nakaguchi4, Hiroji Chibana4, Maria Manuel Lopes5, Ulrich Güldener3,6, Geraldine Butler2, Nuno Pereira Mira1.   

Abstract

The frequent emergence of azole resistance among Candida glabrata strains contributes to increase the incidence of infections caused by this species. Whole-genome sequencing of a fluconazole and voriconazole-resistant clinical isolate (FFUL887) and subsequent comparison with the genome of the susceptible strain CBS138 revealed prominent differences in several genes documented to promote azole resistance in C. glabrata. Among these was the transcriptional regulator CgPdr1. The CgPdr1 FFUL887 allele included a K274Q modification not documented in other azole-resistant strains. Transcriptomic profiling evidenced the upregulation of 92 documented targets of CgPdr1 in the FFUL887 strain, supporting the idea that the K274Q substitution originates a CgPdr1 gain-of-function mutant. The expression of CgPDR1K274Q in the FFUL887 background sensitised the cells against high concentrations of organic acids at a low pH (4.5), but had no detectable effect in tolerance towards other environmental stressors. Comparison of the genome of FFUL887 and CBS138 also revealed prominent differences in the sequence of adhesin-encoding genes, while comparison of the transcriptome of the two strains showed a significant remodelling of the expression of genes involved in metabolism of carbohydrates, nitrogen and sulphur in the FFUL887 strain; these responses likely reflecting adaptive responses evolved by the clinical strain during colonisation of the host. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Candida glabrata; CgPdr1; antifungal resistance; comparative genomics and comparative transcriptomics

Mesh:

Substances:

Year:  2018        PMID: 29087506     DOI: 10.1093/femsyr/fox079

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  12 in total

Review 1.  Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

Authors:  Yunjin Lee; Emily Puumala; Nicole Robbins; Leah E Cowen
Journal:  Chem Rev       Date:  2020-05-22       Impact factor: 60.622

2.  Disclosing azole resistance mechanisms in resistant Candida glabrata strains encoding wild-type or gain-of-function CgPDR1 alleles through comparative genomics and transcriptomics.

Authors:  Sara B Salazar; Maria Joana F Pinheiro; Danielle Sotti-Novais; Ana R Soares; Maria M Lopes; Teresa Ferreira; Vitória Rodrigues; Fábio Fernandes; Nuno P Mira
Journal:  G3 (Bethesda)       Date:  2022-07-06       Impact factor: 3.542

3.  Synthesis, Molecular Docking, and Antimycotic Evaluation of Some 3-Acyl Imidazo[1,2-a]pyrimidines.

Authors:  Omar Gómez-García; Dulce Andrade-Pavón; Elena Campos-Aldrete; Ricardo Ballinas-Indilí; Alfonso Méndez-Tenorio; Lourdes Villa-Tanaca; Cecilio Álvarez-Toledano
Journal:  Molecules       Date:  2018-03-07       Impact factor: 4.411

Review 4.  Candida glabrata's Genome Plasticity Confers a Unique Pattern of Expressed Cell Wall Proteins.

Authors:  Eunice López-Fuentes; Guadalupe Gutiérrez-Escobedo; Bea Timmermans; Patrick Van Dijck; Alejandro De Las Peñas; Irene Castaño
Journal:  J Fungi (Basel)       Date:  2018-06-05

Review 5.  Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens.

Authors:  Ewa Ksiezopolska; Toni Gabaldón
Journal:  Genes (Basel)       Date:  2018-09-19       Impact factor: 4.096

Review 6.  Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection.

Authors:  Pedro Pais; Mónica Galocha; Romeu Viana; Mafalda Cavalheiro; Diana Pereira; Miguel Cacho Teixeira
Journal:  Microb Cell       Date:  2019-02-08

Review 7.  Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata.

Authors:  Kelley R Healey; David S Perlin
Journal:  J Fungi (Basel)       Date:  2018-09-01

8.  A Transcriptomics Approach To Unveiling the Mechanisms of In Vitro Evolution towards Fluconazole Resistance of a Candida glabrata Clinical Isolate.

Authors:  Mafalda Cavalheiro; Catarina Costa; Ana Silva-Dias; Isabel M Miranda; Can Wang; Pedro Pais; Sandra N Pinto; Dalila Mil-Homens; Michiyo Sato-Okamoto; Azusa Takahashi-Nakaguchi; Raquel M Silva; Nuno P Mira; Arsénio M Fialho; Hiroji Chibana; Acácio G Rodrigues; Geraldine Butler; Miguel C Teixeira
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 9.  Candida glabrata: A Lot More Than Meets the Eye.

Authors:  Kundan Kumar; Fizza Askari; Mahima Sagar Sahu; Rupinder Kaur
Journal:  Microorganisms       Date:  2019-01-30

Review 10.  Finding the needle in a haystack: Mapping antifungal drug resistance in fungal pathogen by genomic approaches.

Authors:  Dominique Sanglard
Journal:  PLoS Pathog       Date:  2019-01-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.